advancing innovation to save lives

GHTC director pens AJTMH editorial discussing the importance of the Fogarty Center

Jamie Bay Nishi, director of GHTC, penned an editorial for the American Journal of Tropical Medicine and Hygiene, discussing the importance of the Fogarty International Center at the US National Institutes of Health, calling the center an "unsung hero for global health research and development."
Learn More

Return on innovation

A new report from GHTC examines the impact of US government investment in global health R&D at home and abroad, from delivering lifesaving tools for the world’s most vulnerable people to generating economic and security returns for the United States.
Learn More

Population Council

The Population Council confronts critical health and development issues. Through biomedical, social science, and public health research in 50 countries, we work with our partners to deliver solutions that lead to more effective policies, programs, and technologies that improve lives around the world. Established in 1952 and headquartered in New York, the Council is a nongovernmental, nonprofit organization governed by an international board of trustees. Our Center for Biomedical Research (CBR) conducts research and develops new products and technologies that enable women, men, and young people to protect their reproductive health, stay safe from sexually transmitted infections including HIV, and improve their health and wellbeing.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Patrick McKern
GHTC featured in Devex Twitter chat recap

Tweets by GHTC were featured in Devex's #Health4Security Twitter chat recap, which aimed to discuss US leadership and investment in health for security. 

GHTC featured in Ambassador Dybul's op-ed in The Hill

GHTC was featured in Ambassador Dybul's op-ed in The Hill, covering the returns of global health R&D and the need for robust investment to research and develop life-saving health technologies.

View All News & Events

Community Event

PATH/Matthew Dakin
4th Annual Global Digital Health Forum
Global Digital Health Network, Personal Connected Health Alliance
Learn More

Member Event

PATH/Heng Chivoan
2017 Global Health Landscape Symposium, A New Normal for Global Health: Navigating Today’s Challenges and Opportunities
Global Health Council
Learn More
View All Events
PATH/Evelyn Hockstein
Global health R&D in the US: Smart for California, right for the world

Global health research not only has the potential to save lives and prevent disabilities, it is good business. And Californians agree. A clear majority—58%—agree that global health research is important to the state’s economy, and 70% agree that Americans would be better off if the United States invests in global health research.

Read More
PATH/Gabe Bienczycki
Research Roundup: What we're reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide